Literature DB >> 7049454

In vitro induction of monoclonal antibody-defined T-cell markers in lymphocytes from immunodeficient children by synthetic serum thymic factor (FTS).

M C Bene, G Faure, P Bordigoni, D Olive, J Duheille.   

Abstract

Lymphocytes from five children suffering from ataxia telangectasia or various unclassified immune deficiencies were tested in vitro for their sensitivity to synthetic serum thymic factor (FTS). The percentages of cells bearing T cell markers were elevated after incubation with FTS at graded concentrations (0.25, 2.5 and 25 ng/ml), by microlymphocytotoxicity or indirect immunofluorescence, using monoclonal anti-Lyt1 antibodies. In four cases, more than 30% of the non-T non-B cells acquired the Lyt1 T cell marker. These four children had low levels of circulating FTS. In the fifth child, who had a normal serum FTS level, and in two age-matched controls, there was no significant increase in the percentage of cells bearing the T marker.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7049454      PMCID: PMC1536464     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  14 in total

1.  The isolation of thymopoietin (thymin).

Authors:  G Goldstein
Journal:  Ann N Y Acad Sci       Date:  1975-02-28       Impact factor: 5.691

2.  Studies on thymus products. II. Demonstration and characterization of a circulating thymic hormone.

Authors:  J F Bach; M Dardenne
Journal:  Immunology       Date:  1973-09       Impact factor: 7.397

3.  Appearance of T-cell markers in bone marrow rosette-forming cells after incubation with thymosin, a thymic hormone.

Authors:  J F Bach; M Dardenne; A L Goldstein; A Guha; A White
Journal:  Proc Natl Acad Sci U S A       Date:  1971-11       Impact factor: 11.205

4.  In-vitro demonstration of thymic hormone in the mouse by conversion of precursor cells into lymphocytes.

Authors:  K Komuro; E A Boyse
Journal:  Lancet       Date:  1973-04-07       Impact factor: 79.321

5.  Evidence for a serum-factor secreted by the human thymus.

Authors:  J F Bach; M Papiernik; P Levasseur; M Dardenne; A Barois; H Le Brigand
Journal:  Lancet       Date:  1972-11-18       Impact factor: 79.321

6.  Purification and biological activity of thymosin, a hormone of the thymus gland.

Authors:  A L Goldstein; A Guha; M M Zatz; M A Hardy; A White
Journal:  Proc Natl Acad Sci U S A       Date:  1972-07       Impact factor: 11.205

7.  A simple micro cytotoxicity test.

Authors:  D B Amos; H Bashir; W Boyle; M MacQueen; A Tiilikainen
Journal:  Transplantation       Date:  1969-03       Impact factor: 4.939

8.  Thymosin activity in patients with cellular immunodeficiency.

Authors:  D W Wara; A L Goldstein; N E Doyle; A J Ammann
Journal:  N Engl J Med       Date:  1975-01-09       Impact factor: 91.245

9.  Effect of thymic factors on the differentiation of human marrow cells into T-lympnocytes in vitro in normals and patients with immunodeficiencies.

Authors:  J L Touraine; F Touraine; G S Incefy; R A Good
Journal:  Ann N Y Acad Sci       Date:  1975-02-28       Impact factor: 5.691

10.  Differentiation of T cells induced by preparations from thymus and by nonthymic agents.

Authors:  M P Scheid; M K Hoffmann; K Komuro; U Hämmerling; J Abbott; E A Boyse; G H Cohen; J A Hooper; R S Schulof; A L Goldstein
Journal:  J Exp Med       Date:  1973-10-01       Impact factor: 14.307

View more
  1 in total

1.  Growth hormone treatment stimulates thymulin production in aged dogs.

Authors:  B L Goff; J A Roth; L H Arp; G S Incefy
Journal:  Clin Exp Immunol       Date:  1987-06       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.